Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002050709-25-000011
Filing Date
2025-12-05
Accepted
2025-12-05 16:10:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11559
2 Squadron_ex1.pdf EX-1 48957
  Complete submission text file 0002050709-25-000011.txt   80766
Mailing Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139
Business Address 1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH FL 33139 (702) 514-4174
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92867 | Film No.: 251553066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address P.O. BOX 462 HINSDALE IL 60522
Business Address P.O. BOX 462 HINSDALE IL 60522 8474819500
Squadron Capital Management LLC (Filed by) CIK: 0002050709 (see all company filings)

EIN.: 884254921 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G